Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

ICU TopicsObstetric critical care

ICU · Obstetric critical care

Venous Thromboembolism in Pregnancy

Also known as VTE in pregnancy · DVT in pregnancy · PE in pregnancy · Pregnancy hypercoagulable · LMWH in pregnancy · Massive PE pregnancy · Perimortem Caesarean

Venous thromboembolism is a leading cause of maternal mortality because pregnancy activates all of Virchow triad — stasis (the gravid uterus compresses the IVC, progesterone venodilation, immobility), hypercoagulability (fibrinogen and factors VII, VIII, X and von Willebrand rise, protein S activity falls, fibrinolysis is impaired), and endothelial injury (delivery) — giving at least a 5-fold higher risk than in non-pregnant women with an even greater surge postpartum (a 4- to 10-fold increase across gestation and the puerperium). DVT is commonly left-sided (May-Thurner compression). Diagnosis uses compression ultrasound for DVT and V/Q (preferred) or CTPA for PE — never relying on D-dimer (it rises physiologically as pregnancy progresses) and never withholding imaging for fetal-radiation fears. Treatment is therapeutic LMWH (does not cross the placenta) dosed by current weight with rising requirements across trimesters; warfarin and DOACs are contraindicated antenatally; thrombolysis (alteplase most used) for massive PE; perimortem Caesarean (resuscitative hysterotomy) in arrest.

high14 referencesUpdated 20 Aug 202611 min readVerification in progress

Practise this topic

  • 8 MCQs

Your progress

Saved on this device.

Practise this topic8 MCQs with explanations

Target exams

CICMFFICMEDIC
On this page
Study tools

Your progress

Saved on this device.

Practise this topic8 MCQs with explanations

Target exams

CICMFFICMEDIC
The one-line answer

Venous thromboembolism is a leading cause of maternal mortality because pregnancy activates all of Virchow triad — stasis (the gravid uterus compresses the IVC, progesterone venodilation, immobility), hypercoagulability (fibrinogen and factors VII, VIII, X and von Willebrand rise, protein S activity falls, fibrinolysis is impaired), and endothelial injury (delivery) — giving at least a 5-fold higher risk than in non-pregnant women, with an even greater surge postpartum. DVT is commonly left-sided (May-Thurner). Diagnose with compression ultrasound for DVT and V/Q (preferred) or CTPA for PE — never rely on D-dimer (it rises physiologically as pregnancy progresses) and never withhold imaging for foetal-radiation fears. Treat with weight-based therapeutic LMWH (it does not cross the placenta, and dose requirements rise as pregnancy advances); warfarin and DOACs are contraindicated antenatally; thrombolyse massive PE (alteplase is the most frequently used agent in reported pregnancy series); and perform perimortem caesarean in arrest.[1][2]

Meet the patient

A 32-year-old primigravida at 36 weeks gestation presents with four hours of sudden dyspnoea, right-sided pleuritic chest pain, and a pre-syncopal episode. She has a BMI of 33. Her heart rate is 128, respiratory rate 32, blood pressure 92 over 58, SpO2 88 percent on room air. Her CXR is normal. The ECG shows sinus tachycardia with an S1Q3T3 pattern and T-wave inversion in V1 to V4. Bedside echocardiography shows a dilated hypokinetic right ventricle with McConnell sign.[1][4]

The two questions that frame every obstetric PE stem are the two that decide the next hour: is she haemodynamically stable? (the ESC split — stable gets LMWH, unstable gets reperfusion), and what is the safest way to image her? (V/Q when the CXR is normal, CTPA when it is not). The trap is withholding imaging for fear of foetal radiation — a missed PE kills both.[1][4]

ICU Fellowship (CICM) Pro

Continue reading

You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the ICU Fellowship (CICM) fellowship library.

Sign in to continueSee pricing
References14ShowHide
  1. [1]Kozak M, Cosmi B, Gerotziafas G, et al. Venous thromboembolism in pregnancy: recent advances Pol Arch Intern Med, 2025.PMID 40792350
  2. [2]Bates SM, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy Blood Adv, 2018.PMID 30482767
  3. [3]Rodriguez D, Jerjes-Sanchez C, Fonseca S, et al. Thrombolysis in massive and submassive pulmonary embolism during pregnancy and the puerperium: a systematic review J Thromb Thrombolysis, 2020.PMID 32347509
  4. [4]Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC) Eur Respir J, 2019.PMID 31473594
  5. [5]Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy Kardiol Pol, 2019.PMID 30912108
  6. [6]Lao TT Pulmonary embolism in pregnancy and the puerperium Best Pract Res Clin Obstet Gynaecol, 2022.PMID 35872145
  7. [7]Heavner MS, Zhang M, Bast CE, et al. Thrombolysis for Massive Pulmonary Embolism in Pregnancy Pharmacotherapy, 2017.PMID 28891082
  8. [8]Bates SM, Greer IA, Middeldorp S, et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest, 2012.PMID 22315276
  9. [9]Brenner B Haemostatic changes in pregnancy Thromb Res, 2004.PMID 15507271
  10. [10]Gibson P, Newell K, Sam D, et al. Weight-adjusted dosing of tinzaparin in pregnancy Thromb Res, 2013.PMID 23245654
  11. [11]Rowan J, McLintock C, Taylor R, et al. Prophylactic and therapeutic enoxaparin during pregnancy: indications, outcomes and monitoring Aust N Z J Obstet Gynaecol, 2003.PMID 14712967
  12. [12]Petrie S, Barras M, Lust K, et al. Evaluation of therapeutic enoxaparin in a pregnant population at a tertiary hospital Intern Med J, 2016.PMID 27087147
  13. [13]Rajendran G, Mahalingam S, Ramkumar A, et al. Resuscitative Hysterotomy and Maternal and Neonatal Mortality in Maternal Cardiac Arrest Patients: A Systematic Review and Meta-analysis Can J Cardiol, 2026.PMID 41038532
  14. [14]Hongo T, Yumoto T, Obara T, et al. Advanced resuscitation strategies for cardiac arrest in pregnancy: a systematic review BMC Cardiovasc Disord, 2026.PMID 42271244

Test yourself

Practise what you just read

  • 8 MCQs
ICU Fellowship (CICM) Pro

$29/ monthor $279 / year

The complete ICU Fellowship (CICM) library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousSepsis in PregnancyObstetric critical careNextAnaemia in the ICU — Phlebotomy, Functional Iron & Restrictive TransfusionHaematology / transfusion